Association of Insulin treatment with gastric residue during an esophagogastroduodenoscopy

AbstractThe purpose of this study was investigating the association of glycemic control and diabetic treatment to gastric residue observed during an esophagogastroduodenoscopy. Among 6,592 subjects who had esophagogastroduodenoscopy at our clinic between 2003 and 2019, we retrospectively and longitudinally identified those who had gastric residue during an esophagogastroduodenoscopy. Other data collected were age, sex, diagnosis of diabetes, glycated hemoglobin (HbA1c) and diabetic medication. Cox proportional hazard models were used to assess the association of these data with occurrence of gastric residue. To the best of our knowledge, this is the first retrospective cohort study finding that taking insulin treatment is a risk factor for gastric residue independent of age, sex and diabetes or HbA1c.
Source: Journal of Diabetes Investigation - Category: Endocrinology Authors: Tags: SHORT REPORT Source Type: research